Aldosterone Antagonist Dosing and the Risk of Hyponatremia in Patients With Cirrhosis and Ascites

Aldosterone Antagonist Dosing and the Risk of Hyponatremia in Patients With Cirrhosis and Ascites

Bibliographic Details
Main Authors:	A.S. Vogel, M. Li, S.D. Zucker
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	Gastro Hep Advances
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772572322001121

Similar Items

Management of Ascites in Patients with Cirrhosis: An Update
by: Giacomo Zaccherini, et al.
Published: (2021-11-01)

Clinical Significance and Management of Hyponatremia in Liver Cirrhosis
by: Martin Janičko, et al.
Published: (2023-10-01)

Hyponatremia – unfavourable prognostic factor in hepatic cirrhosis
by: Enescu Aurelia, et al.
Published: (2016-12-01)

Innovative approaches to the management of ascites in cirrhosis
by: Florence Wong
Published: (2023-07-01)

Extracorporal modified ascitic fluid reinfusion in treatment of resistant ascites in liver cirrhosis
by: I. E. Onnintsev, et al.
Published: (2017-06-01)

Evaluation of the definition of hyperdynamic circulation in patients with cirrhosis and ascites
by: Cristina Ripoll, et al.
Published: (2022-12-01)

Efficacy and Safety of Ascites Treatment in Liver Cirrhosis
by: G. A. Ignatenko, et al.
Published: (2022-07-01)

Vasopressin Receptor Antagonists in Hyponatremia: Uses and Misuses
by: Helbert Rondon-Berrios, et al.
Published: (2017-08-01)

Renin, aldosterone, urinary sodium and weight change in cirrhotic patients with ascites and sodium restriction.
by: M P Rocha, et al.
Published: (1986-08-01)

Propranolol use in patients with cirrhosis and refractory ascites: A nationwide study
by: Yen-Chun Chen, et al.
Published: (2022-01-01)

Prognostic value of ascites in patients with liver cirrhosis undergoing cardiac surgery
by: Amila Cizmic, et al.
Published: (2023-10-01)

RESPIRATORY AND SYMPTOMATIC IMPACT OF ASCITES RELIEF BY PARACENTESIS IN PATIENTS WITH HEPATIC CIRRHOSIS
by: Verônica Lourenço WITTMER, et al.
Published: (2020-02-01)

Risk factors for hospital readmission among patients with cirrhosis and ascites in China: a retrospective observational study
by: Na Li, et al.
Published: (2024-01-01)

Optimal resting heart rate and ascites‐related death in patients with cirrhosis and ascites using nonselective beta‐blockers (ORCA)
by: Warunee Mingpun, et al.
Published: (2024-01-01)

Chylous ascites secondary to cirrhosis of the liver: A case report
by: J.P. Piña-Pedraza, et al.
Published: (2015-10-01)

The Role of Transjugular Intrahepatic Portosystemic Shunt for the Management of Ascites in Patients with Decompensated Cirrhosis
by: Giulia Iannone, et al.
Published: (2024-02-01)

Sodium and water intake in patients with cirrhosis and ascites. Physiopathological basis of clinical management
by: G. Pedretti
Published: (2013-05-01)

The First Finding of Cirrhosis: Hepatic Hydrothorax Caused by Absence of Ascites
by: Yahya Atayan, et al.
Published: (2015-06-01)

Liver cirrhosis and chylous ascites. Current disease with unusual presentation
by: Arletis Ferrer Pérez, et al.
Published: (2016-10-01)

Incidence and Associated factors to development of hyponatremia in a cohort of ambulatory patients with compensated liver cirrhosis
by: Marlene López-Sánchez, et al.
Published: (2024-02-01)

Effects of Short-Term Human Albumin Infusion for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis
by: Zhaohui Bai, et al.
Published: (2022-12-01)

Obeticholic Acid Decreases Intestinal Content of Enterococcus in Rats With Cirrhosis and Ascites
by: Kathleen Yan, et al.
Published: (2021-09-01)

The combined impact of hyponatremia and hematocrit on the risk for 90-day readmission and death in patients with heart failure: dilutional hyponatremia versus depletional hyponatremia
by: Jiahuan Rao, et al.
Published: (2023-01-01)

Reappraisal of the Role of Ascitic Fluid Adenosine Deaminase for the Diagnosis of Peritoneal Tuberculosis in Cirrhosis
by: Amol Sonyabapu Dahale, et al.
Published: (2021-09-01)

Non-Selective Beta-Blockers and Risk of Sepsis in Patients with Cirrhosis and Ascites: Results from a Large Observational Study
by: Jensen MD, et al.
Published: (2023-06-01)

The Effects of SGLT2 Inhibitors on Liver Cirrhosis Patients with Refractory Ascites: A Literature Review
by: Yasunori Miyamoto, et al.
Published: (2023-03-01)

A Case of Hydrothorax Aggravated by Peritoneal Dialysate Leakage in Compensated Liver Cirrhosis Patient with Ascites
by: Gain You, et al.
Published: (2014-06-01)

Tunneled Peritoneal Catheter for Refractory Ascites in Cirrhosis: A Randomized Case-Series
by: Nina Kimer, et al.
Published: (2020-10-01)

Evaluation of Hyponatremia and Predictors of Hyponatremia in Patients Hospitalized with the COVID-19
by: Emine Emektar, et al.
Published: (2021-09-01)

ALDOSTERONE ANTAGONISTS. MODERN VIEWS ON THE MECHANISM OF ACTION AND EFFECTS OF SPIRONOLACTONE
by: V. I. Podzolkov, et al.
Published: (2017-05-01)

Hyponatremia Associated with Congestive Heart Failure: Involvement of Vasopressin and Efficacy of Vasopressin Receptor Antagonists
by: San-e Ishikawa, et al.
Published: (2023-02-01)

Validation of a new simple scoring system to predict spontaneous bacterial peritonitis in patients with cirrhosis and ascites
by: Ngoc Cao Huynh, et al.
Published: (2023-08-01)

The Relationship Between the Mean Platelet Volume and the Development of Spontaneous Ascites Fluid Infection in Patients with Decompensated Cirrhosis
by: Ebru Sinem Bilgin, et al.
Published: (2020-10-01)

Use of Human Albumin Administration for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis: A Systematic Review and Meta-Analysis
by: Zhaohui Bai, et al.
Published: (2022-10-01)

The hyponatremias
by: Giovanna Elmi, et al.
Published: (2013-03-01)

Ascites re-compensation in HBV-related first decompensated cirrhosis after anti-viral therapy
by: Mingyu Li, et al.
Published: (2023-01-01)

Beneficial long-term effect of aldosterone antagonist added to a traditional blockade of the renin–angiotensin–aldosterone system among patients with obesity and proteinuria
by: Enrique Morales, et al.
Published: (2015-11-01)

Detection of Endothelin 2 (Et-2) as a novel biomarker of renal dysfunction in patients of liver Cirrhosis with Ascites
by: Amna Qureshi, et al.
Published: (2016-08-01)

Preventive and Treatment Interventions for Abdominal Ascites of Patients with Liver Cirrhosis: A Systematic Review of Randomized Controlled Trials
by: Ferya Çelik, et al.
Published: (2021-06-01)

Hyponatremia in Patients with Hematologic Diseases
by: Epameinondas Koumpis, et al.
Published: (2020-11-01)